APA (7th ed.) Citation

MC, B., M, D., A, C., B, E., JL, M., RM, S., . . . Kendall, D. M. (2009). One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: A randomized, controlled trial. Diabetes Care, 32(5), 762. https://doi.org/10.2337/dc08-1797

Chicago Style (17th ed.) Citation

MC, Bunck, et al. "One-year Treatment with Exenatide Improves Beta-cell Function, Compared with Insulin Glargine, in Metformin-treated Type 2 Diabetic Patients: A Randomized, Controlled Trial." Diabetes Care 32, no. 5 (2009): 762. https://doi.org/10.2337/dc08-1797.

MLA (9th ed.) Citation

MC, Bunck, et al. "One-year Treatment with Exenatide Improves Beta-cell Function, Compared with Insulin Glargine, in Metformin-treated Type 2 Diabetic Patients: A Randomized, Controlled Trial." Diabetes Care, vol. 32, no. 5, 2009, p. 762, https://doi.org/10.2337/dc08-1797.